Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
Prognostic significance of LINE-1 methylation level in the upper gastrointestinal cancer. Prospective study of oncogenic mutations in circulating cell-free DNA (cfDNA) using a multiplex sequencing ...
Both processing methods—formalin-fixed paraffin-embedded (FFPE) and flash-frozen—effectively preserve biospecimens. However, the choice between them depends upon the specific application. BioIVT, ...
Now Shipping Kits for Technology that Brings Single-Cell Resolution to Most Common Archival Format Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results